Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

The Changing Landscape of Drug Pricing: What Pharma Needs to Know in 2025

The landscape of drug pricing in the United States is currently undergoing a period of significant and unprecedented change, marked by potentially transformative reforms. This blog post delves into the intricacies of several key initiatives that are reshaping the pharmaceutical
  • Quality Management System
Drug pricing reforms in the United States are no longer speculative—they are real, enforceable, and imminent.

Understanding Isolators in the Pharmaceutical Industry – A Simple Guide

Pharmaceutical isolators have revolutionized aseptic manufacturing by offering a controlled, contamination-free environment that enhances both product safety and operator protection.
  • Blog, GMP, GxP

The Role of Isolators and RABS in Aseptic Manufacturing

As the pharmaceutical industry continues to evolve, aseptic processing must keep pace with advancing technologies. The choice between Open RABS, Closed RABS, and Isolators is crucial in ensuring sterility, regulatory compliance, and cost-effectiveness in injectable manufacturing.
  • Aseptic Manufacturing, Blog, GMP

What is the CPCA Category for Nitrosamine?

The CPCA for Nitrosamine simplifies the complex process of assessing nitrosamine impurities by categorizing them based on carcinogenic risk.
  • Nitrosamine
Multiethnic team of pharmaceutical researcher studying a new drug for diabetes

How to Calculate Acceptable Intake (AI) Limits for Nitrosamines?

Calculating acceptable intake (AI) limits for nitrosamines in pharmaceuticals is critical to ensuring patient safety. By accurately determining AI limits, we can minimize potential carcinogenic risks and maintain the highest standards of drug safety.
  • Nitrosamine
Researchers Evaluating Nitrosamine Presence to Calculate Acceptable Intake (AI) Limits for Enhanced Drug Safety.

Steps and Tips for Streamlining Medical Devices Complaint Process

Complaint handling is an integral part of medical device companies’ Quality Management System (QMS). It involves receiving, investigating, and resolving customer complaints related to medical device products and services provided by an organization. Such complaints are related to the safety,
  • Complaint management, Medical Devices

FDA BIMO Inspections: Insights for Researchers

The FDA’s Bioresearch Monitoring Program (BIMO) is critical for maintaining the integrity of clinical trials. In this blog, we explore the nuances of BIMO inspections and offer detailed guidance for clinical researchers to navigate these complex evaluations.
  • Audit and Inspection, Quality Management System
FDA inspectors conduct a BIMO inspection to ensure bioresearch compliance and accuracy.

Essential Steps for Conducting Effective Periodic Reviews in CSV

Periodic reviews are conducted throughout the operational life of computerized system to verify that it remains in a validated state, complies with current regulatory requirements, is fit for intended use, and satisfies company policies and procedures. The review should confirm
  • Computerized System Validation, Periodic Review
Periodic Review of Computerized system

Enhancing Security through Periodic User Access Reviews

Periodic user access reviews are essential for maintaining the security and integrity of computer systems in the pharmaceutical industry. They play a crucial role in safeguarding sensitive data and ensuring compliance. This blog explores the importance, challenges, and strategies for
  • Computerized System Validation, Periodic Review
Protection of sensitive data

CSV to CSA: From Compliance to Confidence

Enhance efficiency and compatibility by transitioning from CSV to CSA, ensuring seamless integration across platforms and systems for improved performance and streamlined operations.
  • Computerized System Validation
Emergence of CSA for streamlining compliance in the digital era.